Calamos Supports Greece

Johnson & Johnson

Covid-19: Greece Announces Plans to Reopen Despite High Case Numbers

Greece recorded 831 patients with Covid-19 on ventilators Wednesday, which is 16 fewer than the record-high 847 patients undergoing the invasive treatment in the country yesterday, Tuesday. The country also recorded 3,015 cases of the coronavirus on Wednesday, which marks...

One in Four Greeks Have Received at Least One Vaccine Dose

Greece announced on Monday that more than 2.5 million doses of the coronavirus vaccine have been administered so far to the population.

FDA Calls for Halt to Administration of Johnson & Johnson Vaccine

The USFDA called for a halt to federally-sponsored inoculation campaigns using the Johnson & Johnson vaccine.

Over 2 Million Doses of Coronavirus Vaccine Distributed in Greece

Marios Themistokleous announced on Monday that a total over 2 million doses of the coronavirus vaccine had been distributed in Greece.

US to Make All Adults Eligible for Coronavirus Vaccine April 19

President Biden announced all adult Americans will be eligible to receive vaccines as of April 19, 2021, far ahead of schedule.

Coronavirus Patients Waiting for ICUs in Greece; Most Intubated are Young

Greek health officials stated most intubated coronavirus patients are aged from 35-50 -- and dozens of people are now waiting outside ICUs.

German Cities Suspend Use of AstraZeneca Vaccine After Clotting Incidents

Two of the largest cities in Germany suspended use of the AstraZeneca vaccine in those under 60 after increased reports of blood clotting.

EU Approves Single-Dose Johnson & Johnson Vaccine

The European Medicines Agency, the European Union's pharmaceutical regulator, approved Johnson & Johnson's coronavirus vaccine on Thursday.

Panel Says Single-Dose Johnson & Johnson Vaccine Safe and Effective

A new, single- dose coronavirus vaccine produced by Johnson & Johnson is now set for FDA approval for emergency use.

Stanford’s Professor Ioannidis Weighs In on Coronavirus Vaccines

In an exclusive interview, Stanford University Professor Dr. John Ioannidis assessed the different vaccines being administered around the world.